IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: A role for ERK

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 282, Issue 4 26-4, 2002, Pages

  Moore, Paul E ^a   Church, Trudi L ^a   Chism, David D ^b   Panettieri Jr , Reynold A ^a   Shore, Stephanie A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Asthma; Extracellular regulated kinase; Interleukin; PD 98059; Tumor necrosis factor ; U 0126

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHEMOKINE; CYTOKINE; EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRONCHUS MUSCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 0036083588     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00245.2001     Document Type: Article

References (47)

1. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells
2. PD98059 is a specific inhibitor of mitogen-activated protein kinase in vitro and in vivo
3. Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-ΚB-dependent signaling pathway that is only partially sensitive to dexamethasone
4. IL-13 activates human cultured airway smooth muscle through the IL-13 R alpha1 receptor
5. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice
6. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1β and TNFα: Effects of IL-10 and corticosteroids
7. A synthetic inhibitor of the mitogen-activated protein kinase cascade
8. Identification of a novel inhibitor of mitogen-activated protein kinase
9. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: Overexpression of the nonsignaling interleukin-13 receptor alpha2
10. Human eotaxin is an eosinophil selective chemoattractant that provides a new mechanism to explain tissue eosinophilia
11. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells
12. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells
13. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but is not restricted to a Th2 type response
14. Requirement for IL-13 independently of IL-4 in experimental asthma
15. Inflammation and airway function in asthma: What you see is not necessarily what you get
16. Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle
17. Inflammation of small airways in asthma
18. Interleukin-4 inhibits mitogen-induced proliferation of human airway smooth muscle cells in culture
19. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene
20. Airway smooth muscle as a target in asthma
21. Selective induction of eotaxin release by IL-13 or IL-4 in human airway smooth muscle cells is synergistic with IL-1β
22. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells
23. IL-1β induces eotaxin gene transcription in A549 airway epithelial cells through NF-κB
24. Eotaxin: A potent eosinophil chemoattract cytokine detected in a guinea pig model of allergic airways inflammation
25. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatic patients contributes to the chemotaxis of eosinphils to the site of inflammation
26. Role of ERK MAP kinases in responses of cultured human airway smooth muscle cells to IL-1β
27. Direct effects of IL-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells
28. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells
29. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma
30. Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids
31. Tumor necrosis factor alpha enhances the expression of the interleukin (IL)-4 receptor alpha-chain on endothelial cells increasing IL-4 or IL-13-induced Stat6 activation
32. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a Stat6-dependent mechanism
33. Activation of eotaxin gene transcription by NF-κB and STAT6 in human airway epithelial cells
34. Eotaxin expression and eosinophilic inflammation in asthma
35. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases
36. IL-4 induces eotaxin: A possible mechanism of selective eosinophil recruitment in helminth infection and atopy
37. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6
38. A human airway smooth muscle cell line that retains physiological responsiveness
39. Regulation of TNF-α-induced eotaxin release from cultured human airway smooth muscle cells by β-2-agonists and corticosteroids
40. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper-2 cytokines
41. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor
42. Targeted disruption of the chemokine eotaxin reduced antigen-induced tissue eosinophilia
43. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice
44. Production of the novel CC chemokine MCP-4 by airway cells and comparison of its biologic activity to other CC chemokines
45. IL-13, IL-4, and TNF-alpha regulate IL-4 and IL-13 receptor expression and eotaxin production in human bronchial smooth muscle
46. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts
47. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production